Guillain–Barré syndrome following COVID‐19 vaccine: A case report

Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID‐19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain–Barré Syndrome Follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhari, Mohammad Sadegh, Poorsaadat, Leila, Mahmoodiyeh, Behnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558586/
https://www.ncbi.nlm.nih.gov/pubmed/36254149
http://dx.doi.org/10.1002/ccr3.6451
_version_ 1784807475002736640
author Fakhari, Mohammad Sadegh
Poorsaadat, Leila
Mahmoodiyeh, Behnam
author_facet Fakhari, Mohammad Sadegh
Poorsaadat, Leila
Mahmoodiyeh, Behnam
author_sort Fakhari, Mohammad Sadegh
collection PubMed
description Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID‐19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain–Barré Syndrome Following Sinopharm COVID‐19 Vaccine.
format Online
Article
Text
id pubmed-9558586
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95585862022-10-16 Guillain–Barré syndrome following COVID‐19 vaccine: A case report Fakhari, Mohammad Sadegh Poorsaadat, Leila Mahmoodiyeh, Behnam Clin Case Rep Case Report Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID‐19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain–Barré Syndrome Following Sinopharm COVID‐19 Vaccine. John Wiley and Sons Inc. 2022-10-13 /pmc/articles/PMC9558586/ /pubmed/36254149 http://dx.doi.org/10.1002/ccr3.6451 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Fakhari, Mohammad Sadegh
Poorsaadat, Leila
Mahmoodiyeh, Behnam
Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title_full Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title_fullStr Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title_full_unstemmed Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title_short Guillain–Barré syndrome following COVID‐19 vaccine: A case report
title_sort guillain–barré syndrome following covid‐19 vaccine: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558586/
https://www.ncbi.nlm.nih.gov/pubmed/36254149
http://dx.doi.org/10.1002/ccr3.6451
work_keys_str_mv AT fakharimohammadsadegh guillainbarresyndromefollowingcovid19vaccineacasereport
AT poorsaadatleila guillainbarresyndromefollowingcovid19vaccineacasereport
AT mahmoodiyehbehnam guillainbarresyndromefollowingcovid19vaccineacasereport

Ejemplares similares